Table 5 Comparison of the study’ variables between the second and third phases of the study within each group
Parameters | Lavender Group (Mean ± SD) | Control Group (Mean ± SD) | ||||||
|---|---|---|---|---|---|---|---|---|
Phase II | Phase III | Change | P- value | Phase 2 | Phase 3 | Change | P-value | |
SBP | 133.16 ± 12.20 | 130.34 ± 1.23 | -2.82 ± 0.03 | 0.031* | 137.09 ± 10.04 | 135.85 ± 1.34 | - 1.24 ± 1.29 | 0.153 |
DBP | 78.43 ± 6.87 | 77.98 ± 0.98 | - 0.55 ± 0.25 | 0.132 | 77.69 ± 9.98 | 77.25 ± 0.23 | - 0.44 ± 0.94 | 0.165 |
HR | 69.26 ± 7.76 | 68.84 ± 0.43 | - 0.42 ± 0.81 | 0.061 | 71.68 ± 5.67 | 70.68 ± 0.23 | - 1.00 ± 0.58 | 0.252 |
RR | 16.48 ± 0.78 | 16.12 ± 0.96 | - 0.36 ± 0.12 | 0.101 | 16.82 ± 6.98 | 16.21 ± 0.36 | - 0.61 ± 0.14 | 0.143 |
Spo2 | 97.98% ± 1.96 | 98.23% ± 0.34 | + 0.25% ± 0.25 | 0.112 | 96.78% ± 0.87 | 96.99% ± 0.75 | + 0.21% ± 0.26 | 0.367 |
MDAS | 5.22 ± 0.54 | 3.47 ± 0.84 | - 1.75 ± 0.13 | 0.012* | 7.30 ± 0.98 | 6.96 ± 0.57 | - 0.34 ± 0.21 | 0.140 |
STAI | 70.84 ± 9.91 | 66.41 ± 0.35 | - 4.43 ± 8.60 | 0.001* | 76.02 ± 0.87 | 75.45 ± 0.85 | - 0.57 ± 0.63 | 0.136 |
Pain score | 80.96 ± 0.87 | 69.31 ± 0.42 | - 11.56 ± 0.25 | 0.003* | 90.84 ± 4.76 | 89.14 ± 0.64 | - 1.7 ± 0.37 | 0.077 |